ACR Updates: COVID-19

 

Latest COVID-19 News

A Message from the ACR

On behalf of its more than 7,700 members of the professional rheumatology community, the ACR wishes to express strong support for Dr. Anthony Fauci and his continued and close involvement in the work to address the nation’s response to the COVID-19 pandemic.
ACR Message in Support of Dr. Fauci

ACR Convergence 2020: COVID-19 Sessions

ACR leaders and experts in rheumatology, including Anthony Fauci, MD, shared timely insights about the impact of COVID-19 during ACR Convergence, the ACR’s annual meeting. If you missed the live virtual meeting, you can purchase the On-Demand All-Access Pass for 24/7 access to 200+ educational sessions and oral abstracts, including the COVID-19 specific sessions. On-demand access is available until March 21, 2021.
ACR Convergence 2020 On-Demand All-Access Pass Details

COVID-19 Mental Health and Well-Being Resources

Rheumatologists, healthcare professionals, and patients with rheumatic disease may feel the stress of COVID-19 even more acutely than others. See a curated collection of non-ACR resources suggested by members of the Association of Rheumatology Professionals to promote well-being, manage daily stress, and offer support during these challenging times.
COVID-19 Mental Health and Well-Being Resources

See All Breaking COVID-19 News

 

Practice and Advocacy Resources

ACR COVID-19 practice and advocacy resourcesThe ACR’s COVID-19 Practice and Advocacy Task Force continues to work rapidly to provide support to you during this unprecedented time. You’ll find guidance documents that include approaches to drug shortages, support for telehealth, information about federal stimulus relief aid, and guidance for infusions. Working with experts in COVID-related topics, we are focused on developing meaningful information and resources to help guide you.

Practice and Advocacy Resources

COVID-19 Manufacturer Resources and Patient Assistance Programs  

 

Clinical Guidance for Pediatric Patients

ACR COVID-19 clinical guidance for pediatric patients with rheumatic diseasesThe ACR has developed two new clinical guidance documents for pediatric patients in the context of the COVID-19 pandemic, including for the care of children with pediatric rheumatic disease, and for the management of inflammatory syndromes in children with recent or concurrent infections with SARS-CoV-2, specifically Multisystem Inflammatory Syndrome in Children (MIS-C). All recommendations are based on current knowledge and will be revised as circumstances and evidence evolve.

Clinical Guidance for Pediatric Patients

 

Clinical Guidance for Adult Patients with Rheumatic Diseases

ACR COVID-19 clinical guidance for patients with rheumatic diseasesThe ACR has developed clinical guidance for the care of adult patients with rheumatic diseases during the COVID-19 pandemic. Populations considered include patients with a documented COVID-19 infection, those who are stable following exposure to SARS-CoV-2 (but without known infection), and patients who are stable with no infection or exposure. The recommendations address various treatment options and provide general guidance, as well as direction for when to start, stop, or reduce medications. All recommendations are based on current knowledge and will be revised as circumstances and evidence evolve.

Clinical Guidance for Adult Patients with Rheumatic Diseases

 

Global Rheumatology Alliance

COVID-19 Global Rheumatology AllianceThe COVID-19 Global Rheumatology Alliance, a section of the American College of Rheumatology, is a provider-entered registry aiming to collect data on rheumatology patients with COVID-19 and hopes the information will provide guidance for rheumatology professionals when assessing and treating the infection in patients with rheumatic disease.

The Global Rheumatology Community’s Response to the Worldwide COVID-19 Pandemic  

Help Us Help Patients: Report a COVID-19 Case  

 

Questions and Feedback

Are you experiencing COVID-19 related drug shortages, practice issues, or any other problems? Share your comments and questions with us at COVID@rheumatology.org

Thank you to the corporate supporters of the ACR COVID-19 Emergency Response.

Updated December 2, 2020 at 1:30 PM ET

© 2020 American College of Rheumatology.  All rights reserved.  Website & Privacy Policies | Sitemap | Help | Contact Us